HealthDay - WEDNESDAY, Aug. 22 (HealthDay News) -- The powerful anti-psychotic drug
Risperdal was approved by the U.S. Food and Drug Administration on
Wednesday for use in children and adolescents who have schizophrenia or
bipolar disorder.
Source: http://rss.news.yahoo.com
No comments:
Post a Comment